fbpx Skip to main content

BioCommunique Article

Event will connect US investors to Japanese academia-oriented startup companies, allowing promising startups to explore business opportunities overseas.

Kyoto University Life Science Showcase in San Diego – February 28th

  • 2020-02-06T19:36:00.000+0000
  • San Diego
  • Author: Kyoto University

Japanese biotech startups with novel technologies and US investors have the opportunity to connect and explore business partnerships at KULS2020 on February 28th at the Sanford Consortium for Regenerative Medicine in La Jolla, California. Featured are companies with novel technologies and seeds in life science fields—including pharmaceuticals, regenerative medicine, medical devices, and diagnostics—that originated at Kyoto University, one of Japan’s premier research universities. For US investors, VCs, and technology scouts from pharmaceutical companies, this will be an excellent opportunity to connect with promising startups.

Presenting companies:

  • aceRNA Technologies – Solution provider for new pharmaceutical modalities using RNA switch technology
  • Cyfuse Biomedical – Creation of functional tissue with a novel scaffold-free bio 3D printing technology
  • Department of Drug Discovery for Lung Diseases, Kyoto University – Innovate the drug discovery for respiratory diseases using iPS-cell technology
  • KinoPharma – Innovative therapeutic drug development for cervical intraepithelial neoplasia (CIN) through industry-university collaboration
  • Oligogen – Development of drug and cell therapy products using novel human neural stem cells “OligoGenie”
  • Quadlytics – Offering epilepsy patients world's first clinically approved seizure prediction software
  • Therabiopharma – Development of curcumin monoglucuronide (CMG) as an anticancer drug for phase I/II clinical trials of refractory and rare cancers, glioblastoma and drug-resistant multiple myeloma
More information and registration for KULS2020.